Urinary Incontinence and Overactive Bladder Market Global Size, Growth, Regions, Type and Application, Status Forecast by 2019-2024
Market Research Engine has published a new report titled as “Urinary Incontinence and Overactive Bladder Market Size, By Product (Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity), By Region, Market Analysis Report, Forecast 2019-2024.”
The global urinary incontinence and overactive bladder market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Astellas Pharma Inc., Endo International, Pfizer, Inc., Allergan, PLC., Actavis, Merck & Co., Mylan N.V., Teva Pharmaceutical Industries Limited and Ferring Pharmaceuticals A/S.
Global urinary incontinence and overactive bladder market is segmented based on the product as, Idiopathic Bladder Overactivity and Neurogenic Bladder Overactivity. Global urinary incontinence and overactive bladder market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional urinary incontinence and overactive bladder market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
The urinary incontinence and overactive bladder market size is estimated to show notable gains during the foreseeable time frame owing to increasing investments in R&D together with rising government incentives. Multiplying ageing population will further enhance business growth. Technological development related to clinical studies along with favourable health care reforms is supporting in the industry growth rate between 2018 and 2024.
Minimum side effects, site-specific local drug delivery, and combination therapies are few major industry trends. However, declining factors such as lack of awareness, social stigmas associated with disease, shifting trend towards alternative therapies and treatments, and drug patent expirations are expected to negatively impact the industry size.
Global urinary incontinence and overactive bladder market share consists of several players including Astellas Pharma Inc., Endo International, Pfizer, Inc., Allergan, PLC., Actavis, Merck & Co., Mylan N.V., Teva Pharmaceutical Industries Limited and Ferring Pharmaceuticals A/S.
The Urinary Incontinence and Overactive Bladder Market Research has been segmented as below:
Urinary Incontinence and Overactive Bladder Market, By Product
- Idiopathic Bladder Overactivity
- Neurogenic Bladder Overactivity
Urinary Incontinence and Overactive Bladder Market, By Region
- North America
- Asia Pacific
- Rest of World
The report covers:
- Global urinary incontinence and overactive bladder market estimates & forecast from 2015 to 2024, with CAGR for 2018-2024.
- Comparative market size analysis for 2017 & 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
- Global urinary incontinence and overactive bladder market trends, with detailed analysis on consumer trends & manufacturer trends
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors
- Key areas of investments identifying market opportunities and challenges in forecast timeframe
- Competitive analysis of the industry players along with the overview on strategic management
- Comprehensive company profiles of the major industry players
Reasons to Buy this Report:
- Gain comprehensive insights on the industry trends
- Identify industry opportunities and key growth segments
- Obtain complete market study on the urinary incontinence and overactive bladder market
- Facilitate strategy planning for your company based on the industry dynamics
- Evaluate your competitor’s business segments and portfolios
Request Sample Report from here: https://www.marketresearchengine.com/urinary-incontinence-and-overactive-bladder-market
Table of Contents:
- Research Methodology
- Executive Summary
- Market Overview
4.2.1. Drugs developed for alternative delivery systems
4.2.2. Drug Pipeline
4.3.1. Effect of yoga on urinary incontinence
4.4.1. New class of treatment for overactive bladders
4.4.2. Merger and acquisition among industry players
4.5.1. Drug patent expirations
- Urinary Incontinence and Overactive Bladder Market, By Product
- Competitive Landscape
- Company Profile
7.1. Astellas Pharma Inc.
7.1.1. Company Overview
7.1.2. Product/Service Landscape
7.1.3. Financial Overview
7.1.4. Recent Developments
7.2. Endo International
7.2.1. Company Overview
7.2.2. Product/Service Landscape
7.2.3. Financial Overview
7.2.4. Recent Developments
7.3. Pfizer, Inc.
7.3.1. Company Overview
7.3.2. Product/Service Landscape
7.3.3. Financial Overview
7.3.4. Recent Developments
7.4. Allergan, PLC.
7.4.1. Company Overview
7.4.2. Product/Service Landscape
7.4.3. Financial Overview
7.4.4. Recent Developments
7.5.1. Company Overview
7.5.2. Product/Service Landscape
7.5.3. Financial Overview
7.5.4. Recent Developments
7.6. Merck & Co.
7.6.1. Company Overview
7.6.2. Product/Service Landscape
7.6.3. Financial Overview
7.6.4. Recent Developments
7.7. Mylan N.V.
7.7.1. Company Overview
7.7.2. Product/Service Landscape
7.7.3. Financial Overview
7.7.4. Recent Developments
7.8. Teva Pharmaceutical Industries Limited
7.8.1. Company Overview
7.8.2. Product/Service Landscape
7.8.3. Financial Overview
7.8.4. Recent Developments
7.9. Ferring Pharmaceuticals A/S
7.9.1. Company Overview
7.9.2. Product/Service Landscape
7.9.3. Financial Overview
7.9.4. Recent Developments
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States